IFP Advisors’s Kyntra Bio KYNB Stock Holding History

IFP Advisors’s Portfolio KYNB Stock Details KYNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1	Closed	-$1K	–	4556
2021 Q4	$1K	Hold	1	–	–	﹤0.01%	2993
2021 Q3	$1K	Buy	+1	New	+$354	﹤0.01%	3017
2021 Q2	–	Sell	-53	Closed	-$30.5K	–	3113
2021 Q1	$45K	Buy	53 +6	+13%	+$6.39K	﹤0.01%	1512
2020 Q4	$40K	Sell	47 -23	-33%	-$24.2K	﹤0.01%	1521
2020 Q3	$72K	Buy	70 +11	+19%	+$11.8K	﹤0.01%	1141
2020 Q2	$60K	Hold	59	–	–	﹤0.01%	1134
2020 Q1	$50K	Buy	59 +2	+4%	+$1.99K	0.01%	1117
2019 Q4	$66K	Sell	57 -4	-7%	-$4.08K	0.01%	1135
2019 Q3	$60K	Buy	+61	New	+$67K	﹤0.01%	1284
2019 Q1	–	Hold	0	–	–	–	2695
2018 Q4	–	Hold	0	–	–	–	3637
2018 Q3	–	Sell	-1	Closed	-$1.54K	–	3885
2018 Q2	$2K	Buy	+1	New	+$1.3K	﹤0.01%	3576
2018 Q1	–	Hold	0	–	–	–	3773
2017 Q4	–	Hold	0	–	–	–	3895
2017 Q3	–	Hold	0	–	–	–	4112

Other funds holding KYNB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

IFP Advisors's KYNB Position: Q1 2022 in Review

IFP Advisors sold out of Kyntra Bio (KYNB) in Q1 2022, closing a stake of 1 share — an estimated $1K sold.

IFP Advisors first reported a position in KYNB in Q2 2018 and held it in 10 quarters. The position peaked at $72K in Q3 2020. 156 funds tracked by Wall St. Rank hold KYNB as of Q1 2022.

IFP Advisors reported no remaining Kyntra Bio position as of Q1 2022 after selling out during the quarter.
IFP Advisors sold 1 Kyntra Bio share in Q1 2022, an estimated $1K.
IFP Advisors first reported a position in Kyntra Bio in Q2 2018 and held it in 10 quarters.
IFP Advisors's Kyntra Bio position peaked at $72K in Q3 2020.
156 funds tracked by Wall St. Rank held Kyntra Bio as of Q1 2022.

Based on IFP Advisors's 13F filing for Q1 2022, filed 8 Aug 2022.